Related Experiment Videos

Unintentional ingestion of bupropion in children

Henry A Spiller1, George M Bosse, Michael Beuhler

  • 1Kentucky Regional Poison Center of Kosair Children's Hospital, Louisville, Kentucky 40232-5070, USA.

Insights

Most children with unintentional bupropion ingestion do not require emergency department visits. Ingestions of 10 mg/kg or less may be safely managed at home, reducing healthcare facility referrals.

Area of Science:

  • Pediatric Toxicology
  • Emergency Medicine
  • Pharmacovigilance

Background:

  • Unintentional bupropion ingestion in young children (< 6 years) has a low reported seizure incidence (0.2%).
  • Despite this, over 80% of these cases are referred to the Emergency Department (ED) for evaluation.

Purpose of the Study:

  • To determine if all unintentional pediatric bupropion ingestions necessitate referral to a healthcare facility (HCF).
  • To identify the proportion of cases that can be safely managed at home.

Main Methods:

  • Retrospective chart review of bupropion ingestions in children under 6 years old (2000-2006).
  • Data sourced from four regional poison centers.
  • Exclusion criteria included lack of follow-up or co-ingestion of other drugs.

Main Results:

  • Out of 407 patients, 81% were seen in an HCF, with 35% requiring hospitalization.
  • 19% of patients were managed at home.
  • Symptoms occurred in 18% of cases, most commonly sinus tachycardia (12.3%), nausea/vomiting, and hyperactivity. Seizures were rare (n=3).
  • 88% of patients with known dosages ingested less than 20 mg/kg.

Conclusions:

  • A significant percentage of children with unintentional bupropion ingestion are still seen in HCFs.
  • Clinical effects from unintentional bupropion ingestion rarely necessitate HCF intervention.
  • Isolated unintentional bupropion ingestions of ≤10 mg/kg may not require HCF referral.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...